PMID- 30430968 OWN - NLM STAT- MEDLINE DCOM- 20190718 LR - 20190718 IS - 0317-1671 (Print) IS - 0317-1671 (Linking) VI - 45 IP - 6 DP - 2018 Nov TI - Low-Intensity Ultrasound Decreases Ischemia-Induced Edema by Inhibiting N-Methyl-d-Aspartic Acid Receptors. PG - 675-681 LID - 10.1017/cjn.2018.331 [doi] AB - BACKGROUND: We have previously shown that low-intensity ultrasound (LIUS), a noninvasive mechanical stimulus, inhibits brain edema formation induced by oxygen and glucose deprivation (OGD) or treatment with glutamate, a mediator of OGD-induced edema, in acute rat hippocampal slice model in vitro. METHODS: In this study, we treated the rat hippocampal slices with N-methyl-d-aspartic acid (NMDA) or (S)-3,5-dihydroxyphenylglycine (DHPG) to determine whether these different glutamate receptor agonists induce edema. The hippocampal slices were then either sonicated with LIUS or treated with N-methyl-d-aspartic acid receptor (NMDAR) antagonists, namely, MK-801 and ketamine, and observed their effects on edema formation. RESULTS: We observed that treatment with NMDA, an agonist of ionotropic glutamate receptors, induced brain edema at similar degrees compared with that induced by OGD. However, treatment with DHPG, an agonist of metabotropic glutamate receptors, did not significantly induce brain edema. Treatment with the NMDAR antagonists MK-801 or ketamine efficiently prevented brain edema formation by both OGD and NMDA in a concentration-dependent manner. N-Methyl-d-aspartic acid-induced brain edema was alleviated by LIUS in an intensity-dependent manner when ultrasound was administered at 30, 50, or 100 mW/cm2 for 20 minutes before the induction of the edema. Furthermore, LIUS reduced OGD- and NMDA-induced phosphorylation of NMDARs at Y1325. CONCLUSION: These results suggest that LIUS can inhibit OGD- or NMDA-induced NMDAR activation by preventing NMDAR phosphorylation, thereby reducing a subsequent brain edema formation. The mechanisms by which LIUS inhibits NMDAR phosphorylation need further investigation. FAU - Hada, Binika AU - Hada B AD - 1Department of Biomedical Sciences,Inha University College of Medicine,Incheon,Korea. FAU - Karmacharya, Mrigendra Bir AU - Karmacharya MB AD - 2Department of Physiology and Biophysics,Inha University College of Medicine,Incheon,Korea. FAU - Park, So R AU - Park SR AD - 2Department of Physiology and Biophysics,Inha University College of Medicine,Incheon,Korea. FAU - Choi, Byung H AU - Choi BH AD - 1Department of Biomedical Sciences,Inha University College of Medicine,Incheon,Korea. LA - eng PT - Journal Article PL - England TA - Can J Neurol Sci JT - The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques JID - 0415227 RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Receptors, Amino Acid) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (aspartic acid receptor) RN - 3KX376GY7L (Glutamic Acid) RN - 6384-92-5 (N-Methylaspartate) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Excitatory Amino Acid Antagonists/*pharmacology MH - Glucose/metabolism MH - Glutamic Acid/metabolism MH - Hippocampus/metabolism/physiopathology MH - Male MH - N-Methylaspartate/*pharmacology MH - Rats, Sprague-Dawley MH - Receptors, Amino Acid/drug effects/metabolism MH - Receptors, N-Methyl-D-Aspartate/drug effects/*metabolism MH - *Ultrasonography/adverse effects OTO - NOTNLM OT - N-Methyl-d-aspartate receptor OT - Brain edema OT - Ischemia OT - Low-intensity ultrasound OT - Oxygen and glucose deprivation EDAT- 2018/11/16 06:00 MHDA- 2019/07/19 06:00 CRDT- 2018/11/16 06:00 PHST- 2018/11/16 06:00 [entrez] PHST- 2018/11/16 06:00 [pubmed] PHST- 2019/07/19 06:00 [medline] AID - S0317167118003311 [pii] AID - 10.1017/cjn.2018.331 [doi] PST - ppublish SO - Can J Neurol Sci. 2018 Nov;45(6):675-681. doi: 10.1017/cjn.2018.331.